Lundbeck News
Most Popular Lundbeck Story
Elan's stock rises on rumor of Lundbeck bid
Elan's stock is on the rise as rumors circulate that the Dublin-based developer could be the target of a takeover attempt by H. Lundbeck. For some time now, Elan has been harshly criticised for its... Read more...
Latest Headlines
- July 30, 2009
- July 7, 2009
- June 26, 2009
- May 13, 2009
- April 8, 2009
- March 26, 2009
- February 10, 2009
- October 2, 2007
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
